# A Study on Median Effective Concentration of Ciprofol Combined With Remifentanil Via Target-controlled Infusion for Inhibiting Tracheal Intubation Stimulation Under qNOX Index Monitoring

> **NCT07462949** · NA · COMPLETED · sponsor: **Guangzhou General Hospital of Guangzhou Military Command** · enrollment: 70 (actual)

## Conditions studied

- Elective Surgery
- Target Controlled Infusion (TCI)
- Noxious Stimuli
- Tracheal Intubation Stimulation

## Interventions

- **DRUG:** Cipofol combined with remifentanil administered via target-controlled infusion

## Key facts

- **NCT ID:** NCT07462949
- **Lead sponsor:** Guangzhou General Hospital of Guangzhou Military Command
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-03-03
- **Primary completion:** 2026-04-03
- **Final completion:** 2026-04-06
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07462949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07462949, "A Study on Median Effective Concentration of Ciprofol Combined With Remifentanil Via Target-controlled Infusion for Inhibiting Tracheal Intubation Stimulation Under qNOX Index Monitoring". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07462949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*